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Abstract: A great deal of effort has been focused on exploring the underlying molecular 
mechanism of osteoarthritis (OA) especially at the cellular level. We report a confocal 
Raman spectroscopic investigation on human osteoarthritic chondrocytes. The objective of 
this investigation is to identify molecular features and the stage of OA based on the 
spectral signatures corresponding to bio-molecular changes at the cellular level in 
chondrocytes. In this study, we isolated chondrocytes from human osteoarthritic cartilage 
and acquired Raman spectra from single cells. Major spectral differences between the  
cells obtained from different International Cartilage Repair Society (ICRS) grades of 
osteoarthritic cartilage were identified. During progression of OA, a decrease in protein 
content and an increase in cell death were observed from the vibrational spectra. Principal 
component analysis and subsequent cross-validation was able to associate osteoarthritic 
chondrocytes to ICRS Grade I, II and III with specificity 100.0%, 98.1%, and 90.7% 
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respectively, while, sensitivity was 98.6%, 82.8%, and 97.5% respectively. The overall 
predictive efficiency was 92.2%. Our pilot study encourages further use of Raman 
spectroscopy as a noninvasive and label free technique for revealing molecular features 
associated with osteoarthritic chondrocytes. 
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1. Introduction 
Osteoarthritis (OA) is a complex musculoskeletal disorder. It is a leading cause of disability among 
elderly people and is a major public health issue with increasing individual and socioeconomic burden. 
It was recently found that it is the fastest increasing major health condition in terms of the global  
rank: “Years lived with disability (YLD)” [1]. Although the use of the Kellgren-Lawrence (K/L) score 
obtained by radiography is a widely accepted method for the diagnosis of OA, several studies have 
demonstrated the complexity involved in early-stage diagnosis [2–4]. 
The origin of OA is not exactly clear and the understanding about the etiology of OA is 
continuously evolving. There are several reports which review the changes observed during 
progression of OA [5,6]. It is believed that the disease primarily affects the articular cartilage and the 
associated underlying bone. The prominent histological changes in cartilage are erosion, fibrillation, 
clefts, chondromalacia, loss of metachromasia, duplication of tidemark and cloning of chondrocytes. 
The underlying cause of these macroscopic and microscopic structural features is the change in 
biochemical compositions such as alteration and decrement in content of proteoglycan [7]. Biochemical 
changes are triggered by expression of enzymes, which are responsible for the breakdown of matrix 
components. It is believed that expression of such enzymes occurs due to the imbalance in cell 
homeostasis, i.e., increased catabolic activity by chondrocytes [8]. Several studies also show that 
progression of OA is associated with increased chondrocyte cell death [6,9,10]. Investigations at the 
cellular level are, therefore, important in understanding the progression of OA as well as other 
cartilage disorders. 
Raman spectroscopy has recently attracted attention because it shows the potential for minimally 
invasive, label free, and objective diagnostics at molecular level. The advantage of a label free 
technique is that it provides the information from the target molecules that are not modified. Therefore, 
all processes in the target molecules are undisturbed and the cells do not show a stress reaction 
attributable to an external label [11]. Raman spectroscopy is a laser based vibrational spectroscopic 
technique and has numerous times successfully demonstrated early detection of neoplasia, differentiation 
of tumors grades, and been useful in providing sub-cellular information from the living cells [12,13]. 
However, to the knowledge of author, this is the first report on Raman spectroscopy of osteoarthritic 
human chondrocytes. The aim of this pilot study is to demonstrate the capabilities of Raman 
spectroscopy for single cell analysis in order to identify major changes in the spectroscopic signatures 
of the cells during the progression of OA. In addition, we have demonstrated that based on biochemical 
compositions at cellular level, Raman spectroscopy is capable to distinguish the chondrocytes isolated 
from different stages (ICRS Grade-I, II and III) of osteoarthritic cartilage. 
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2. Results and Discussion 
A comparison between the mean (of n = 150) spectra of ICRS Grade-I, II and III is shown in  
Figure 1. Mean spectra represent the average characteristics of each grade. Typically, Raman spectra 
obtained from biological samples are complex in nature, consisting of superimposed Raman peaks 
associated with the various bio-molecular constituents of the cell. Hence, visual interpretation of  
the mean spectra obtained from a large variety of cells is not straightforward. However a careful  
qualitative evaluation of the mean spectra can provide an insight into the bio-compositional changes at 
the cellular level during the progression of OA. In order to confirm that the subtle differences involved 
in the spectra are from variation of the Raman signals and not from the fluorescence background,  
the variance between the mean spectra of the three different cell types (Grade I, II and III) at each 
wavelength positions was plotted (Supplementary Figure S1). The plot of variance vs. wavelength 
expressed major Raman peaks (and not fluorescence background) associated with cellular biochemical 
components which are described in next section. 
 
Figure 1. Normalized mean (n = 150) Raman spectra of chondrocytes which were  
isolated from osteoarthritic cartilage of ICRS Grade-I, II and III. Spectra are vertically 
offset for clarity. 
The main aim of this analysis was to investigate if Raman spectroscopy could be used to identify 
biomolecular changes at the cellular level and potentially discriminate chondrocytes which were  
isolated from different stages (ICRS Grade-I, II and III) of osteoarthritic cartilage. The major spectral 
changes in chondrocytes obtained from different stages of osteoarthritic cartilage can be found by  
a qualitative analysis of the mean spectra (Figure 1). The Raman spectra clearly indicate changes in 
protein vibrations. The magnitude of the area (Figure 2a) represented by amide I (1612–1696 cm−1) 
decreases consistently with an increase in the grade of OA. This observation was supported by similar 
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trend (Figure 2b,c) shown by the content of amide III (1229–1300 cm−1) and phenylalanine  
(1001–1007 cm−1/peak at 1004 cm−1). These observations indicate a general decrease in protein  
content inside chondrocytes in higher grades of OA. Moreover, decrease in protein content was 
observed with decrease in the content of the nucleic acid (780–794 cm−1/peak at 785 cm−1) in cells 
which may correlate with the enhancement of internucleosomal DNA cleavage [14] during progression 
of disease (Figure 2e). 
As another observation, intensity of the spectral band 1302–1307 cm−1/peak at 1304 cm−1 is 
increasing with progression of OA (Figures 1 and 2d). This peak may be attributed to the lipids [15–19]. 
In the earlier reports, it was hypothesized that increased lipid deposition may be associated with the 
advancement of OA [20–23]. Our observation indicates that this peak could be an indicator of lipid 
deposition and hence, supports the earlier hypothesis that lipid deposition may play a role in progression 
of OA. However, other alternative interpretation (e.g., amide III and/or nucleobase) besides lipids 
might also be possible relevant to the peak of 1304 cm−1 [15]. Therefore, more experimental studies 
are necessary to verify the contribution of lipid during progression of the disease. 
 
Figure 2. Cont. 




Figure 2. A relative comparison for the content of amide-I (a); amide-III (b); phenylalanine 
(c); lipid (d); and DNA/RNA (e) in osteoarthritic chondrocytes (n = 150 cells). These 
chondrocytes were isolated from osteoarthritic cartilage section of ICRS Grade-I, II and 
III. Data represents the normalized mean area of Raman band and bar represents the 
standard error. 
In order to test the capability of Raman spectroscopy, spectra were compared objectively by  
applying multivariate analysis technique, using ICRS as a gold standard. To elucidate and visualize  
the hidden biochemical information, principal component analysis (PCA) was performed on the total  
data-set which were acquired from 450 samples (cells). PCA is a common multivariate statistical 
method that is often used in bioanalytical Raman spectroscopy to reduce dimensionality and to identify 
combinations of the most important spectral markers which maximizes the data variance and optimizes 
group separation [24,25]. It is performed over the data sets with the aim of comparing spectral data in 
terms of similarities and differences in an unsupervised manner [26]. The results of the PCA analysis 
are shown in Figure 3. The spectra of chondrocytes associated with the three different ICRS grades of 
OA appeared as distinct clusters when plotted against the three main PCs that explain maximum  
variance in the data set. The tightness and separation of the clusters illustrates how easily the analytes 
can be discriminated. In order to quantitatively assess discrimination capability, prediction accuracy 
was tested subsequently using leave one out full cross-validation technique using Mahalanobis 
distance as a discriminator. Several reports recommend full cross-validation as a general approach to 
prediction testing, claiming that this should provide most comprehensive testing of the model [27,28].  
The classification matrix summarizes the correct and incorrect classification of the spectra (Table 1). 
The specificities for ICRS Grade I, II and III were 100.0%, 98.1%, and 90.7% respectively, while,  
the sensitivities were 98.6%, 82.8%, and 97.5% respectively. The overall predictive efficiency  
was 92.2%. Additionally, the segmented [27] cross-validation (a segment of 10 spectra at a time)  
showed similar result in terms of overall predictive efficiency (91.8%). Our analysis shows that the 
chondrocytes obtained from grade-I osteoarthritic cartilage, were classified with higher accuracy than 
other grades. Misclassifications mainly occurred between the chondrocytes of grade II and III (Figure 3), 
which indicates that chondrocytes associated with ICRS grade II and III are more heterogeneous in 
biochemical compositions than ICRS Grade-I. During progression of OA the quality of articular 
cartilage degrades and chondrocytes respond in order to cope with physiochemical changes occurred in 
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extracellular matrix [29,30]. In this context, our result indicates that to a greater extent most 
chondrocytes available in ICRS Grade-I cartilage are in similar stage, but, the partial overlap  
between the cluster of ICRS Grade-II and Grade-III indicate that all chondrocytes associated with 
macroscopically higher grade (i.e., Grade-II and III) of osteoarthritic cartilage are not in same stage  
of degradation. 
 
Figure 3. Multivariate-analysis based principal component analysis (PCA) algorithm 
classifies different osteoarthritic chondrocytes cells associated with ICRS Grade I, II and 
III into separate clusters. 
Table 1. Classification matrix provides the information about classification ability and 
prediction efficiency of PCA algorithm. 
Sample: Chondrocytes Grade-I Grade-II Grade-III 
Grade-I (150) 150 0 0 
Grade-II (150) 2 145 3 
Grade-III (150) 0 30 120 
Loading vector is associated to the original Raman spectrum by a variable called PC score, which 
represents the weight of that particular component against the basis spectrum [31]. Loading vectors 
(Figure 4) associated with three main principle components (PC-1, PC-2 and PC-3) were plotted.  
These plots are mainly composed of Raman peaks, which indicate that the major variations in the data 
are due to Raman signals and not fluorescence background. Loadings associated with PC-1, PC-2 and 
PC-3 explains 82.30%, 7.06% and 3.75% of the total variance in the data set, respectively. Combined, 
these three PCs explain 93.11% of the total variation in the data set. The most important spectral 
features which appeared in the loading plots were tentatively assigned [15,18] to amide-I (1657 cm−1), 
protein and carbohydrate (1451 cm−1), DNA/RNA (1341 cm−1), lipid and protein (1304 cm−1), amide-III 
(1267 cm−1), nucleic acids (1094 cm−1), phenylalanine (1004 cm−1) and DNA/RNA (785 cm−1). 
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However, a few peaks (e.g., 1379 and 1490 cm−1) are remained unassigned for human cells and require 
further investigation. 
 
Figure 4. Loading plots relevant to PC1, PC2 and PC3, which are mainly responsible for 
the discrimination among different clusters of chondrocytes cells associated with different 
grades of osteoarthritic cartilage. 
Fixation of cells may induce spectral changes. Acetone and alcohol (e.g., methanol and ethanol) 
dissolve lipids. Therefore, other fixatives like formalin and 4% paraformaldehyde was considered as  
a better option for the fixation. As shown in previous spectroscopic studies using cultured cells  
that formalin fixation was found to affect the cellular lipid and protein content [32,33]. Ten percent 
formalin with fixation times of several hours are considered much harsher conditions than 4% 
paraformaldehyde that could lead to dehydration due to fixation [34]. Although fixation with 4% 
paraformaldehyde also induces changes in the Raman spectrum of a cell, the induced changes are 
small compared to the alcohol [34]. Moreover, with longer duration of fixation time, larger spectral 
changes were observed [34]. Therefore, 4% paraformaldehyde with mild fixation time (~10 min) was 
chosen to be optimal for the Raman study. However, additional studies are needed to find the fixation 
induced Raman changes due to the 4% paraformaldehyde especially in the chondrocytes. 
Due to erosion and thinning in high grade OA [35–37], it is difficult to isolate the chondrocytes 
from a given cartilage layer (for example, superficial layer). Therefore, spectra were acquired from  
a large number of randomly chosen cells that were isolated from the whole volume (bulk) of the 
osteoarthritic cartilage. Hence, the spectra represent the chondrocyte characteristics of the bulk 
cartilage rather than a specific layer of cartilage. Thus, the spectral differences are associated with 
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biochemical difference in OA severities (and not only the chondrocyte characteristics associated with 
different cartilage layer). 
Due to ethical considerations, biopsies of normal (healthy) cartilage from human knee were not 
obtained in this study. Although our study includes the detection of osteoarthritic grades at cellular 
level, it should be noted that clinical diagnosis of OA is not performed at cellular level. Biopsy of early  
stage cartilage and then, isolation of chondrocytes for diagnostic purposes is not intended to be 
performed in clinical practice. Nevertheless, detailed knowledge of OA at cellular level is highly 
desirable. Enhanced understanding will help in exploring underlying mechanism and thus, in early 
diagnosis that may lead towards correct treatment and prevention of OA. 
3. Materials and Methods 
3.1. Human Osteoarthritic Cartilage Sections 
The use of human samples was approved by the Regional Committee for Medical Research Ethics 
(2013/265 REK, Norway). Human articular cartilage samples were obtained from the femoral condyle 
of osteoarthritic patients undergoing total replacement knee surgery. In order to consider the case of 
primary OA, only those patients that had not suffered previous knee injury and had not undergone 
other prior surgery were included in the study. To reduce age-associated variation in the articular 
cartilage, all patients selected in this study were older than 65 years. It should be pointed out that 
different grades of osteoarthritic cartilage may be present within one femoral head of the knee joint. 
The grading of cartilage sections was based on the standard (International Cartilage Repair Society) 
ICRS classification (Supplementary Table S1) [38,39]. The assignment of ICRS grade to the  
cartilage sections was performed by two experienced orthopedic surgeons, who were blinded to the 
classification of each other. Only sections assigned a similar ICRS grade by both orthopedic surgeons 
were included in this study. In this pilot study, 15 specimens in total, 5 specimens of each ICRS Grade 
(Grade I, II and III) were included (for details please refer to Supplementary Figure S2). All tissue 
sections included in this study were obtained from load bearing area (medial) of the femoral condyle of 
the knee. Only osteoarthritic cartilage specimens of ICRS Grade I, II and III, but not Grade-IV, were 
included in the study. As described in the ICRS classification scheme, at the location of ICRS Grade IV 
(i.e., advanced stage of OA), underlying bone is exposed and almost no cartilage present. Therefore, 
ICRS Grade-IV specimens were not included in this study. 
3.2. Isolation of Chondrocytes (Cells) 
Isolation of chondrocytes from all osteoarthritic cartilage specimens was performed by enzymatic 
(collagenase) digestion process. A typical image of osteoarthritic cartilage and isolated single cells is 
shown in Figure S3. To isolate chondrocytes, firstly, cartilage sections were divided into several pieces 
(~1–2 mm) using a surgical scalpel. Incubation of trimmed cartilage was then performed for ~18 h in  
2–5 mL of Dulbecco’s Modified Eagle’s Medium (DMEM) containing 0.8 mg/mL collagenase from 
clostridium histolyticum (C6885; Sigma-Aldrich, Saint Louis, MO, USA) and 50 μg/mL gentamicin 
(G1397; Sigma-Aldrich). Filtration of the digested cartilage was performed through a 50 μm filter. 
Centrifugation of the filtered cells was performed at 1500 rmp for 5 min. Pelleted cells were 
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resuspended in phosphate buffer saline (PBS) solution. Centrifugation and resuspension in PBS was 
repeated second time. Finally, cells were fixed by 4% pararfomaldehyde for the time duration of  
10 min. Cells in PBS suspension were stored at 4 °C. 
3.3. Raman Spectroscopy 
Raman spectra were acquired using a standard confocal Raman microscope (LabRam HR800, 
HORIBA Jobin Yvon, Villeneuve-d'Ascq, France). The 632.10 nm laser light was focused by an 
Olympus (Tokyo, Japan) 60×, 1.2 NA water-immersion microscope objective. Cells sedimented in a 
well on a CaF2 slide and were covered by a 100 µm quartz cover-slip. 30 Raman spectra were acquired 
from 30 randomly chosen cells associated with each specimen (Supplementary Figure S2). Therefore, 150 
(30 × 5 specimens) spectra were collected from each ICRS grade (Grade I, II, and III). In total, 450 
(150 × 3 Grades) spectra obtained from 450 samples (cells) were used in this investigation (Figure S2). 
Spectra were acquired over the Raman shift region 600–1725 cm−1 (fingerprint region). The acquisition 
time of each spectrum was 90 s. During acquisition of data, the laser power at the surface of the sample 
was 8 mW. In order to minimize biochemical heterogeneity of different cell compartments (e.g., nucleus, 
cytoplasm, membrane), during each data acquisition, the laser was focused in the nucleus of the cell. 
However, due to inherent features such as multiple scattering and the large size of the confocal  
volume [40,41] the system might also partially examine the perinuclear structures. As described by 
Pudlas et al. [42], the collected Raman signals predominantly represents molecular bonds of the cell 
nuclei. In order to reduce the fluorescence background and enhance the comparability of the spectra, 
the raw Raman spectra were pre-processed by removal of cosmic rays (narrow noise spikes), 
subtraction of background spectra (the corresponding spectra of PBS suspension which were acquired 
after the change of every focus) and smoothing (Savitzky-Golay filter: 3rd order, 9 point). Spectra 
were then subjected to extended multiplicative signal correction (EMSC) [43], followed by peak 
normalization (1004 cm−1). The plots for the normalized mean (n = 150) area of the corresponding 
Raman band of interest were plotted with standard error. Spectral band assignment of sharp peaks  
(i.e., 785, 1004 and 1304 cm−1) for the calculation of peak area was performed according to full width 
at half maxima (FWHM). Statistical comparisons were performed using one-way analysis of variance 
(ANOVA) and a p-value of less than 0.05 was considered as statistically significant. The data analysis 
was performed in Matlab (The MathWorks, Natick, MA, USA). 
4. Conclusions 
In summary, as a proof-of-principle study, we demonstrated Raman spectroscopy as a noninvasive 
and label free technique that can detect subtle biomolecular changes in osteoarthritic chondrocytes. 
The relative changes in protein, lipid and RNA content in chondrocytes at different stages of OA may 
help in exploring the underlying mechanism of the disease at cellular level. Additionally, we have shown 
that with high specificity and sensitivity, it can discriminate the cells obtained from the different stages 
of osteoarthritic cartilage. Our analysis might be helpful in the development of Raman spectroscopy 
technique to monitor OA progression at the cellular level. Further correlation and validation of novel 
Raman spectral features of chondrocytes using supervised/unsupervised techniques in combination 
with clinical gold-standard may help Raman spectroscopy to achieve its full potential. Nevertheless, 
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our study encourages further investigations; for example: characterization of proteins [44,45], mapping 
of single cells [19,46,47], quantitative comparison of biochemical compositions (e.g., DNA/RNA, 
lipid, collagen, total protein content) [48] in different stage osteoarthritic chondrocytes, which may 
further reveal hidden features associated with progression of OA at cellular and sub-cellular level. 
Supplementary Materials 
Supplementary materials can be found at http://www.mdpi.com/1422-0067/16/05/9341/s1. 
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